Dehydroevodiamine hydrochloride
CAS No. 111664-82-5
Dehydroevodiamine hydrochloride ( —— )
Catalog No. M20378 CAS No. 111664-82-5
Dehydroevodiamine (DHE) a natural compound isolated from Evodia rutaecarpa can inhibit AChE. It has hypotensive and neuroprotective effects and modulates nitric oxide production.
Purity : >98% (HPLC)
Size | Price / USD | Stock | Quantity |
5MG | 35 | In Stock |
|
10MG | 51 | In Stock |
|
25MG | 81 | In Stock |
|
50MG | 119 | In Stock |
|
100MG | 176 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDehydroevodiamine hydrochloride
-
NoteResearch use only not for human use.
-
Brief DescriptionDehydroevodiamine (DHE) a natural compound isolated from Evodia rutaecarpa can inhibit AChE. It has hypotensive and neuroprotective effects and modulates nitric oxide production.
-
DescriptionDehydroevodiamine (DHE) a natural compound isolated from Evodia rutaecarpa can inhibit AChE. It has hypotensive and neuroprotective effects and modulates nitric oxide production.
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetAChR
-
RecptorAChE
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number111664-82-5
-
Formula Weight337.8
-
Molecular FormulaC19H16ClN3O?
-
Purity>98% (HPLC)
-
SolubilityDMSO:37 mg/mL (109.53 mM)
-
SMILES[Cl-].C[n+]1c2-c3[nH]c4ccccc4c3CCn2c(=O)c2ccccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Dicyclomine hydrochl...
A muscarinic antagonist used as an antispasmodic and in urinary incontinence. It has little effect on glandular secretion or the cardiovascular system.
-
(+)-Pilocarpine hydr...
Pilocarpine hydrochloride is a nonselective muscarinic acetylcholine receptor agonist used to produce an experimental model of epilepsy.
-
Catestatin
Non-competitive nicotinic cholinergic antagonist; selectively inhibits nicotinic-stimulated catecholamine secretion from chromaffin cells and noradrenergic neurons (IC50 ~ 200 nM). Blocks nicotinic-induced cationic signaling (IC50 ~ 200 - 250 nM) and inhibits nicotinic-agonist induced desensitization of catecholamine release. Also stimulates mast cell release of histamine via a separate mechanism.